West Pharmaceutical Services, Inc. (WST) — Analysis Summary
West Pharmaceutical Services, Inc. (WST) has a market cap of $23.75B with year-over-year revenue growth of +6.3%. Net margin stands at 16.1%. The stock trades at a P/E ratio of 42.0.
Key Takeaways
- Revenue changed +6.3% year-over-year
- Net margin of 16.1%
- P/E ratio of 42.0
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, WST posted revenue growth of +6.3% and trades at a P/E of 42.0.
West Pharmaceutical Services, Inc. (WST)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
10,800
Headquarters
EXTON, PA
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.88
Dividend Yield
0.26%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.